drugset
drugset / Trial / NCT03760900

Safety of Autologous Cord Blood Cells for Preterm Infants.

NCT03760900 ↗

Phase 0 Completed 15 enrolled Guangdong Women and Children Hospital
NaSingle-groupOpen-labelPrevention

Summary

To assess the safety of autologous volume- and red blood cell (RBC)-reduced non-cryopreserved umbilical cord blood (UCB) cell infusion to preterm infants.

Timeline

Start
2009-01-01
Primary completion
2010-01-01
Completion
2016-06-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Umbilical Cord Blood Stem Cells Therapy Cell therapy 5e+07 cells/kg —

Indications

No indication recorded.